Skip to main content

Table 4 Model 3 results on the associations between sleep duration and abnormal serum lipid levels stratified by sex and age

From: Night sleep duration and risk of each lipid profile abnormality in a Chinese population: a prospective cohort study

Sleep duration (h)

Women

Men

Age < 60

Age ≥ 60

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

TC

 ≤ 5

1.04(0.89–1.23)

0.596

0.95(0.85–1.06)

0.135

1.01(0.92–1.10)

0.868

0.88(0.75–1.05)

0.156

 6.0

1.07(0.95–1.21)

0.269

1.01(0.99–1.12)

0.690

1.02(0.96–1.08)

0.530

0.95(0.83–1.09)

0.478

 7.0

reference

 

reference

 

reference

 

reference

 

 8.0

0.98(0.89–1.07)

0.600

1.05(0.99–1.12)

0.737

0.99(0.94–1.04)

0.670

1.07(0.94–1.20)

0.307

 ≥ 9

1.04(0.82–1.33)

0.724

1.08(0.91–1.29)

0.270

0.97(0.84–1.12)

0.694

0.88(0.61–1.25)

0.464

TG

 ≤ 5

1.11(0.89–1.40)

0.349

0.95(0.85–1.06)

0.338

1.04(0.94–1.16)

0.424

0.73(0.56–0.96)

0.022

 6.0

1.14(0.96–1.34)

0.134

1.01(0.94–1.09)

0.735

1.04(0.97–1.12)

0.297

0.99(0.81–1.21)

0.941

 7.0

reference

 

reference

 

reference

 

reference

 

 8.0

1.08(0.95–1.23)

0.224

1.05(0.99–1.12)

0.105

1.05(0.99–1.12)

0.090

1.00(0.84–1.21)

0.920

 ≥ 9

1.21(0.88–1.67)

0.238

1.08(0.91–1.29)

0.388

1.08(0.92–1.27)

0.339

1.11(0.70–1.76)

0.664

LDL-C

 ≤ 5

1.30(1.01–1.67)

0.039

0.98(0.86–1.11)

0.710

1.17(1.03–1.33)

0.019

0.77(0.60–1.00)

0.047

 6.0

1.09(0.90–1.34)

0.380

1.01(0.92–1.11)

0.856

1.06(0.96–1.16)

0.257

0.93(0.76–1.14)

0.492

 7.0

reference

 

reference

 

reference

 

reference

 

 8.0

1.33(1.15–1.55)

< 0.001

1.17(1.08–1.27)

< 0.001

1.21(1.12–1.31)

< 0.001

1.25(1.05–1.48)

0.013

 ≥ 9

1.26(0.86–1.84)

0.232

0.94(0.73–1.20)

0.600

1.05(0.84–1.31)

0.668

0.81(0.48–1.37)

0.427

HDL-C

 ≤ 5

0.99(0.85–1.16)

0.921

1.02(0.96–1.09)

0.511

1.01(0.94–1.09)

0.782

1.03(0.92–1.15)

0.624

 6.0

1.03(0.92–1.16)

0.633

1.01(0.96–1.06)

0.630

1.02(0.97–1.08)

0.396

0.97(0.88–1.07)

0.588

 7.0

reference

 

reference

 

reference

 

reference

 

 8.0

1.06(0.97–1.16)

0.178

1.10(1.06–1.15)

< 0.001

1.10(1.05–1.15)

< 0.001

1.11(1.02–1.21)

< 0.05

 ≥ 9

1.14(0.91–1.44)

0.249

1.25(1.12–1.41)

< 0.001

1.24(1.10–1.39)

< 0.001

1.12(0.90–1.40)

0.317

Dyslipidemia

 ≤ 5

1.14(0.98–1.31)

0.086

0.94(0.88–1.01)

0.098

1.03(0.96–1.11)

0.418

0.85(0.74–0.98)

0.027

 6.0

1.15(1.01–1.28)

0.010

1.03(0.98–1.09)

0.243

1.07(1.02–1.12)

0.011

0.99(0.89–1.11)

0.902

 7.0

reference

 

reference

 

reference

 

reference

 

 8.0

1.03(0.95–1.12)

0.452

1.03(0.98–1.07)

0.245

1.01(0.97–1.05)

0.700

1.10(0.99–1.22)

0.062

 ≥ 9

1.13(0.92–1.39)

0.253

0.97(0.85–1.10)

0.587

1.02(0.91–1.14)

0.763

0.89(0.67–1.18)

0.427

  1. Model 3 was adjusted for age (stratified by sex), sex (stratified by age), education, smoking, alcohol, physical activity, snoring, hypertension, diabetes mellitus, body mass index, and C-reactive protein
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X